Browsing by Author Thomas, H.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2006Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.Marx, Gavin; Yip, Desmond; Cheong, K.; Chrystal, K.; Galani, E.; Gallagher, C.; Harper, P. G.; Lofts, F.; Steer, Christopher B.; Strickland, A. H.; Thomas, H.; Centre Regional Ed - Orange; MedicineGemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study., Gynecologic oncology, vol.103,(2),2006,pp 439-445
2002A phase II trial of ZD0473 in platinum-pretreated ovarian cancerBeale, Philip; Atkinson, R.J.; Bougnoux, P.; Cure, H.; Dirix, L.; Gore, M.E; Rischin, D.; Smit, W.M; Thomas, H.; Central Clinical School: MedicineA phase II trial of ZD0473 in platinum-pretreated ovarian cancer, European Journal Of Cancer, vol.38,(18),2002,pp 2416-2420
2002Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free intervalBeale, Philip; Atkinson, R.J.; Bougnoux, P.; Cure, H.; Dirix, L.; Gore, M.E; Rischin, D.; Smit, W.M; Thomas, H.; Central Clinical School: MedicineResults of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval, European Journal Of Cancer, vol.38,(supplement 8),2002,pp s7-s12